Early Diagnosis of Non-Cystic Fibrosis Bronchiectasis in Childhood: Shedding Light on Barriers and Opportunities

Michele Ghezzi1, Maria Di Cicco2,3, Giulia Canali1

  • 1Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.

Pediatric Pulmonology
|November 25, 2025
PubMed

Insights

Early diagnosis of bronchiectasis in children is crucial. Identifying this lung condition sooner can halt disease progression and prevent structural lung damage, improving outcomes for pediatric patients.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine

Background:

  • Bronchiectasis is a chronic respiratory syndrome marked by persistent cough, mucus, and bronchial dilation.
  • Diagnosis typically relies on high-resolution chest tomography.
  • Childhood bronchiectasis is often underdiagnosed, despite the long progression from initial bronchitis.

Purpose of the Study:

  • To analyze barriers to timely diagnosis of non-cystic fibrosis bronchiectasis in children.
  • To explore novel strategies for enhancing diagnostic algorithms and patient care.

Main Methods:

  • Review of diagnostic challenges in pediatric bronchiectasis.
  • Discussion of potential improvements in diagnostic approaches.

Main Results:

  • Significant barriers exist for the early detection of bronchiectasis in pediatric populations.
  • New diagnostic avenues and patient management opportunities are identified.

Conclusions:

  • Prompt diagnosis in children is essential to interrupt the infection-inflammation cycle.
  • Early intervention can reverse or halt disease progression and lung injury.
  • Further research is needed for pediatric to adult care transition programs.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
456
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
687
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K